[1] Neuschwander-Tetri BA. Therapeutic landscape for NAFLD in 2020. Gastroenterology. 2020 Feb 13. [Epub ahead of print]
[2] Neuschwander-Tetri BA. Too Much Sugar-The Not-So-Sweet Reality of Its Impact on Our Health. Hepatology,2020,71:377-379.
[3] Schwimmer JB, Ugalde-Nicalo P, Welsh JA, et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: A randomized clinical trial. JAMA, 2019,321:256-265.
[4] Sanders FWB, Acharjee A, Walker C, et al. Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption. Genome Biol,2018,19:79.
[5] Beysen C, Ruddy M, Stoch A, et al. Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans. Am J Physiol Endocrinol Metab, 2018,315:E126-E132.
[6] Schwarz JM, Noworolski SM, Erkin-Cakmak A, et al. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology, 2017, 153:743-752.
[7] 贺雯茜, 杨金玉,徐艳娇,等. 果糖诱导肝脂肪变性细胞模型建立及评价. 肝脏,2019, 24 (6): 638-642. |
